Skeletal Histomorphometry in Patients on Teriparatide or Zoledronic Acid Therapy.
Phase of Trial: Phase IV
Latest Information Update: 01 Jul 2016
At a glance
- Drugs Teriparatide (Primary) ; Zoledronic acid
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms SHOTZ
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 05 Oct 2013 Twenty-four month results presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.
- 15 Oct 2012 Results from this trial presented at the 34th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR), according to an Eli Lilly media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History